Cargando…

SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance

Detalles Bibliográficos
Autores principales:	Zhang, Xiantao, Wu, Shijian, Wu, Bolin, Yang, Qirui, Chen, Achun, Li, Yuzhuang, Zhang, Yiwen, Pan, Ting, Zhang, Hui, He, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678971/ https://www.ncbi.nlm.nih.gov/pubmed/34921135 http://dx.doi.org/10.1038/s41392-021-00852-5

Ejemplares similares

A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2
por: Yuan, Yaochang, et al.
Publicado: (2022)

Omicron spike protein: a clue for viral entry and immune evasion
por: Behrens, G. M. N., et al.
Publicado: (2022)

Exhibition | Microcosm | 11 June - 19 December | Free Entrance
Publicado: (2014)

Antibody response and cross-neutralization after Omicron BA.2 infection
por: Zhang, Yiwen, et al.
Publicado: (2023)

Structural Basis for the Enhanced Infectivity and Immune Evasion of Omicron Subvariants
por: Li, Yaning, et al.
Publicado: (2023)

SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
por: Aggarwal, Anupriya, et al.
Publicado: (2022)

Project Gatekeeper: An Entrance Control System Embedded Radiation Detection Capability for Security Applications
por: Martin, Peter G., et al.
Publicado: (2020)

Omicron: Master of immune evasion maintains robust ACE2 binding
por: Hoffmann, Markus, et al.
Publicado: (2022)

Understanding Omicron: Transmissibility, immune evasion and antiviral intervention
por: Hoffmann, Markus, et al.
Publicado: (2022)

T-cell immunity: a barrier to Omicron immune evasion
por: Yu, Fei, et al.
Publicado: (2022)

Engineering potent live attenuated coronavirus vaccines by targeted inactivation of the immune evasive viral deubiquitinase
por: Myeni, Sebenzile K., et al.
Publicado: (2023)

Entrance Qualifications
Publicado: (1899)

Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75
por: Cao, Yunlong, et al.
Publicado: (2022)

Immune Evasion of SARS-CoV-2 Omicron Subvariants
por: Ke, Hanzhong, et al.
Publicado: (2022)

Evasion of neutralising antibodies by omicron sublineage BA.2.75
por: Sheward, Daniel J, et al.
Publicado: (2022)

A novel tumor-targeting strain of Xenorhabdus stockiae exhibits potent biological activities
por: Zhang, Chao, et al.
Publicado: (2022)

Viral mechanisms of immune evasion
por: Alcami, Antonio, et al.
Publicado: (2000)

Viral mechanisms of immune evasion
por: Alcami, Antonio, et al.
Publicado: (2000)

Viral mechanisms of immune evasion
por: Alcami, Antonio, et al.
Publicado: (2000)

Entrance A 2015
por: Nunes, Rui
Publicado: (2015)

One entrance into life.
por: Morrison, J. E.
Publicado: (1975)

Point 5's entrance.
por: Margot Frenot
Publicado: (2000)

An Entrance Examination for Probationers
Publicado: (1920)

The Entrance of the Spermatozoon into the Ovum
por: Keber, M.
Publicado: (1854)

Standard of Entrance Raised
Publicado: (1898)

The Future Entrance Standard
Publicado: (1898)

Intracellular sensing of viral genomes and viral evasion
por: Lee, Hyun-Cheol, et al.
Publicado: (2019)

Cytosolic and nuclear recognition of virus and viral evasion
por: Li, Siji, et al.
Publicado: (2021)

Antibody evasion properties of SARS-CoV-2 Omicron sublineages
por: Iketani, Sho, et al.
Publicado: (2022)

Structural basis of Omicron immune evasion: A comparative computational study
por: Contractor, Darshan, et al.
Publicado: (2022)

Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB
por: Uraki, Ryuta, et al.
Publicado: (2023)

Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron
por: Wang, Lidong, et al.
Publicado: (2023)

SARS-CoV-2 Omicron: a new challenge for pandemic and vaccine
por: Zhang, Xiantao, et al.
Publicado: (2022)

The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι
por: Zhang, Yiwen, et al.
Publicado: (2021)

Development of Receptor Binding Domain (RBD)‐Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS‐CoV‐2 Delta and Other Variants
por: Chen, Ran, et al.
Publicado: (2022)

A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross‐Protection Activity against Multiple SARS‐CoV‐2 Sublineages
por: Zhang, Xiantao, et al.
Publicado: (2023)

Interferons: Signaling, antiviral and viral evasion
por: Bonjardim, Cláudio A., et al.
Publicado: (2009)

Buildings at the "B entrance" of CERN
por: CERN PhotoLab
Publicado: (1957)

Remodelling of Point 1's entrance.
por: Jean-Luc Caron
Publicado: (1998)

Blocking the Entrance to Open the Gate
por: Schrauwen, Patrick, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tl5co38aa1cumk8ahln7vp2icl